Detection of anti-p53 autoantibodies in saliva using microfluidic chips for the rapid screening of oral cancer

Research output: Contribution to journalJournal Article peer-review

22 Scopus citations

Abstract

Autoantibodies have high specificity and stability and are easy to detect. Anti-p53 autoantibodies can be used as biomarkers for the early detection of oral cancer. However, most studies detected anti-p53 in sera samples. In this study, a microfluidic chip combined with magnetic immunoassay, which can automatically detect the concentration of anti-p53 in saliva, was developed. The use of a micromixer can shorten the immunoassay time: the mixing time of the antigen and antibody can be reduced from the original 60 min off-chip to 20 min, making the total immunoassay time around 60 min. A method of moving magnetic beads and the antibody instead of manipulating fluid was utilized to simplify fluid control and decrease contamination caused by non-specific protein adsorption to the surface of reaction wells. The detection limit of anti-p53 was 4 ng mL-1. In addition, a relative concentration of anti-p53 in the saliva of patients was detected in the chip.

Original languageEnglish
Pages (from-to)15513-15521
Number of pages9
JournalRSC Advances
Volume8
Issue number28
DOIs
StatePublished - 2018

Bibliographical note

Publisher Copyright:
© 2018 The Royal Society of Chemistry.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Detection of anti-p53 autoantibodies in saliva using microfluidic chips for the rapid screening of oral cancer'. Together they form a unique fingerprint.

Cite this